Both in Biotechnology
ImmunityBio vs Immunovant
Over the past year IBRX returned +245.4% and IMVT returned +18.2%; their daily moves had a correlation of 0.26.
IBRX +245.4% IMVT +18.2%Growth of $1, one year, split-adjusted
| Metric | IBRX | IMVT |
|---|---|---|
| Price | $8.29 | $29.17 |
| Market cap | $8.79B | $6.03B |
| Today | −5.15% | −1.59% |
| 1 month | −10.7% | −13.3% |
| 6 months | +16.6% | +7.6% |
| Year to date | +318.7% | +14.8% |
| 1 year | +242.6% | +34.7% |
| Revenue growth (YoY) | +93.9% | — |
| Gross margin | 99.4% | — |
| Net margin | −449.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 53.0× | — |
| Net cash | -$57.7M | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 68.0% | 36.8% |
| Short % of float | 31.1% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).